DOWN-REGULATING GENE EXPRESSION IN INSECT PLANTS

    公开(公告)号:US20210254093A1

    公开(公告)日:2021-08-19

    申请号:US17195247

    申请日:2021-03-08

    申请人: Devgen NV

    IPC分类号: C12N15/82 C12N15/113

    摘要: The present invention relates to the prevention and/or control of infestation by insect pest species. In particular, the invention relates to down-regulation of expression of target genes in insect pests using interfering ribonucleic acid (RNA) molecules. Also described are transgenic plants that (i) express or are capable of expressing interfering RNAs of the invention and (ii) are resistant to infestation by insect pest species. Compositions containing the interfering RNAs of the invention are also provided.

    CONTROL OF INSECT PESTS USING RNA MOLECULES

    公开(公告)号:US20210123069A1

    公开(公告)日:2021-04-29

    申请号:US17051048

    申请日:2019-04-17

    申请人: DEVGEN NV

    IPC分类号: C12N15/82 A01N63/60

    摘要: Disclosed are double stranded RNA molecules that are toxic to flea beetles, particularly the flea beetle species Psylliodes chrysocephala, Phyllotreta nemorum, Phyllotreta striolata, Phyllotreta armoraciae, and Phyllotreta cruciferae. In particular, interfering RNA molecules capable of interfering with pest target genes and that are toxic to the target pest are provided. Further, methods of making and using the interfering RNA, for example in transgenic plants or as the active ingredient in a composition, to confer protection from insect damage are disclosed.

    Kinase Inhibitors
    16.
    发明申请
    Kinase Inhibitors 审中-公开
    激酶抑制剂

    公开(公告)号:US20090233960A1

    公开(公告)日:2009-09-17

    申请号:US12083408

    申请日:2006-10-13

    摘要: The present invention relates to new AGC kinase inhibitors, in particular to compounds of Formula I, II, or III or a stereoisomer, tautomer, racemic, metabolite, pro- or predrug, salt, hydrate, or solvate thereof, I II III wherein X, R1, R2, R3, R31, n, and m have the meaning defined in the claims. In particular, the present invention relates more specifically to ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease.

    摘要翻译: 本发明涉及新的AGC激酶抑制剂,特别是涉及式I,II或III的化合物或其立体异构体,互变异构体,外消旋,代谢物,前体或前药,盐,水合物或溶剂合物,其中X ,R1,R2,R3,R31,n和m具有权利要求中限定的含义。 特别地,本发明更具体地涉及包含这种抑制剂的ROCK抑制剂,组合物,特别是药物,以及这些抑制剂在治疗和预防疾病中的用途。

    Alcohol dehydrogenase sequences useful for developing compounds for the prevention and/or treatment of metabolic diseases
    19.
    发明申请
    Alcohol dehydrogenase sequences useful for developing compounds for the prevention and/or treatment of metabolic diseases 审中-公开
    用于开发用于预防和/或治疗代谢性疾病的化合物的醇脱氢酶序列

    公开(公告)号:US20070092910A1

    公开(公告)日:2007-04-26

    申请号:US10561098

    申请日:2004-06-17

    CPC分类号: C12N9/0006

    摘要: The present invention relates to nucleotide sequences, particularly those of SEQ ID NO's 2, 7 and 9 that encode and may be used to express amino acid sequences that are useful in the identification and development of compounds for the prevention and treatment of metabolic diseases such as diabetes and obesity. The invention also relates to the amino acid sequences—such as proteins and/or polypeptides—that are encoded by, and that may be obtained by suitable expression of, the nucleotide sequences of the invention, particularly those set out in SEQ ID NO's 1, 6 and 8. The invention further relates to genetic constructs, host cells and organisms that have been transformed with the nucleotide sequences of the invention and that can express the amino acid sequences of the invention and methods and compositions which utilize the nucleotide and amino acid sequences of the invention.

    摘要翻译: 本发明涉及编码并可用于表达可用于鉴定和开发用于预防和治疗代谢性疾病的化合物的氨基酸序列的核苷酸序列,特别是SEQ ID NO:2,7和9的核苷​​酸序列, 糖尿病和肥胖。 本发明还涉及由本发明的核苷酸序列,特别是SEQ ID NO:1中列出的那些的核苷酸序列编码并且可以通过适当表达获得的氨基酸序列 - 例如蛋白质和/或多肽 - 本发明还涉及已经用本发明的核苷酸序列转化并可以表达本发明的氨基酸序列的遗传构建体,宿主细胞和生物体,以及利用核苷酸和氨基酸序列的方法和组合物 的本发明。